16 A sub-study of the SURPASS-3 trial on overweight/obese patients with T2DM demonstrated that tirzepatide decreased liver fat by 8.1% over 52 weeks, along with significant reductions in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (NCT03882970), 17 indicating that tirzepatide may improve liver steatosis or inflammation
Understanding why this combination works helps researchers design more effective protocols
In April, I began using Mounjaro, and its been a game-changer for me
A 2007 study conducted in Russia found that epithalon extended the lifespan of rats exposed to natural and constant illumination [9]
Key drivers shaping the market include heightened clinical awareness of the benefits of GLP-1 receptor agonists in weight management and cardiometabolic risk reduction
Fatigue was slightly more likely with semaglutide, while injection site reactions were reported more with tirzepatide